ITGB1 and hepatocellular carcinoma: Additionally, on the basis of TCGA data, we found that a high level of ITGB1 expression in HCC patients was strongly associated with high pathological stages as well as poor survival, indicating that ITGB1 might potentially serve as a poor prognostic biomarker in HCC progression.